FDA Approves Vowst, the First Oral Fecal Microbiota Product to Prevent C. diff Infections
The Food and Drug Administration (FDA) of the United States has given its approval to the use of fecal microbiota transplantation (FMT) as a therapy for recurring infections caused by…